SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-07-000124
Filing Date
2007-02-14
Accepted
2007-02-14 21:50:30
Documents
7
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a27255e10vq.htm 10-Q 365214
2 EXHIBIT 15.1 a27255exv15w1.htm EX-15.1 2362
3 EXHIBIT 31.1 a27255exv31w1.htm EX-31.1 6887
4 EXHIBIT 31.2 a27255exv31w2.htm EX-31.2 6934
5 EXHIBIT 32.1 a27255exv32w1.htm EX-32.1 2562
6 EXHIBIT 32.2 a27255exv32w2.htm EX-32.2 2609
7 GRAPHIC a27255a2725501.gif GRAPHIC 10656
  Complete submission text file 0000936392-07-000124.txt   402922
Mailing Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656
Business Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-15803 | Film No.: 07625166
SIC: 2834 Pharmaceutical Preparations